Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jasper Therapeutics Q2 EPS $(0.29)

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.29) per share.
byMichael Horton
August 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.29) per share.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: North American Q2 Earnings

By Benzinga Insights
July 27, 6:08 PM
North American (NYSE:NOA) reported its Q2 earnings results on Wednesday, July 27, 2022 at 05:00 PM. Here's what investors need to know about the announcement. Earnings North American missed estimated earnings by 45.83%, reporting an EPS of $0.13 versus an estimate of $0.24.

NOA